These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 2631798

  • 1. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M, Garrido A, Algarra I, Caballero A, Delgado C, Collado MD, Fernández-Cruz E, Garrido F.
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [Abstract] [Full Text] [Related]

  • 2. Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.
    Garrido A, Pérez M, Delgado C, Garrido ML, Rojano J, Algarra I, Garrido F.
    Exp Clin Immunogenet; 1986; 3(2):98-110. PubMed ID: 3274051
    [Abstract] [Full Text] [Related]

  • 3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R, Luescher B, Cerottini JC, MacDonald HR.
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the syngeneic anti-tumour response against the GR9 tumour with the production of isoantisera and monoclonal antibodies.
    Delgado C, Garrido A, Pérez M, Garrido ML, Algarra I, Garrido F.
    J Immunogenet; 1986 Aug; 13(2-3):169-77. PubMed ID: 3819451
    [Abstract] [Full Text] [Related]

  • 7. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
    Ogata M, Shimizu J, Kosaka H, Maekawa R, Shimizu K, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
    Garrido ML, Pérez M, Delgado C, Rojano J, Algarra I, Garrido A, Garrido F.
    J Immunogenet; 1986 Nov; 13(2-3):159-67. PubMed ID: 3819450
    [Abstract] [Full Text] [Related]

  • 9. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [Abstract] [Full Text] [Related]

  • 10. An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis.
    Mazzocchi A, Rodolfo M, Parmiani G, Anichini A.
    Melanoma Res; 1991 Oct; 1(3):169-76. PubMed ID: 1841713
    [Abstract] [Full Text] [Related]

  • 11. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
    Brondz BD, Kahn ES, Chervonsky AV, Isakova VR, Apasov SG, Blandova ZK.
    Exp Clin Immunogenet; 1987 Oct; 4(4):211-21. PubMed ID: 2978841
    [Abstract] [Full Text] [Related]

  • 12. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 13. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K.
    Cancer Res; 1993 Jan 01; 53(1):106-11. PubMed ID: 8093229
    [Abstract] [Full Text] [Related]

  • 14. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F, Jongeneel V, Cerottini JC, Brunner KT.
    Eur J Immunol; 1976 Nov 01; 6(11):823-9. PubMed ID: 187429
    [Abstract] [Full Text] [Related]

  • 15. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
    Chen Z, Rosten SI, Lord EM, Gaspari AA.
    Reg Immunol; 1993 Nov 01; 5(5):285-92. PubMed ID: 8148238
    [Abstract] [Full Text] [Related]

  • 16. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG, Sitkovsky MV.
    J Immunol; 1994 Mar 01; 152(5):2087-97. PubMed ID: 8133027
    [Abstract] [Full Text] [Related]

  • 17. Recognition by cytotoxic T lymphocytes of Qa-2 antigens. Sensitivity of Qa-2 molecules to phosphatidylinositol-specific phospholipase C.
    Mann D, Forman J.
    J Immunol; 1988 Sep 15; 141(6):1813-8. PubMed ID: 2459191
    [Abstract] [Full Text] [Related]

  • 18. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML, Parenza M, Parmiani G.
    J Natl Cancer Inst; 1983 Feb 15; 70(2):291-7. PubMed ID: 6571938
    [Abstract] [Full Text] [Related]

  • 19. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
    Kuribayashi K, Tanaka C, Matsubayashi Y, Masuda T, Udono H, Abe M, Nakayama E, Shiku H.
    J Immunol; 1988 Dec 01; 141(11):4074-80. PubMed ID: 2460558
    [Abstract] [Full Text] [Related]

  • 20. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M, Wada H, Honda S, Tawara I, Uenaka A, Kanematsu T, Nakayama E.
    J Immunol; 1999 Jun 01; 162(11):6420-5. PubMed ID: 10352255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.